Bombesin and bombesin antagonists: Studies in Swiss 3T3 cells and human small cell lung cancer
1988
Bombesin and Its Antagonists in Lung Cancer Research
publication
Evidence: moderate
Author Information
Author(s): P.J. Woll, E. Rozengurt
Primary Institution: Imperial Cancer Research Fund
Hypothesis
Bombesin may act as an autocrine growth factor for small cell lung cancer (SCLC).
Conclusion
Bombesin antagonists can inhibit the growth of SCLC in vitro, suggesting potential therapeutic applications.
Supporting Evidence
- Bombesin is secreted by human small cell lung cancers and may act as an autocrine growth factor.
- Antagonists can reversibly inhibit the growth of SCLC in vitro.
- Specific bombesin receptors were identified in Swiss 3T3 cells.
Takeaway
Bombesin is a substance that helps cancer cells grow, and scientists are testing ways to block it to stop the cancer from growing.
Methodology
The study used Swiss 3T3 cells to investigate the effects of bombesin and its antagonists on cell growth and DNA synthesis.
Limitations
The study primarily focuses on in vitro results, which may not fully translate to in vivo conditions.
Want to read the original?
Access the complete publication on the publisher's website